{
    "organizations": [],
    "uuid": "f9ba0c2fe88570d273b2f15120add82a66919641",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-genomic-health-oncotype-dx-genomic/brief-genomic-health-oncotype-dx-genomic-prostate-score-test-increases-use-of-active-surveillance-idUSFWN1PV0TW",
    "ord_in_thread": 0,
    "title": "BRIEF-Genomic Health - Oncotype DX Genomic Prostate Score™ Test Increases Use Of Active Surveillance",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 5 (Reuters) - Genomic Health Inc:\n* ONCOTYPE DX® GENOMIC PROSTATE SCORE™ TEST INCREASES USE OF ACTIVE SURVEILLANCE BY 30 PERCENT IN LOW-RISK PATIENTS, RESULTING IN GREATER ADHERENCE TO GUIDELINE-BASED CARE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-05T21:37:00.000+02:00",
    "crawled": "2018-02-07T00:14:20.018+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "genomic",
        "health",
        "inc",
        "oncotype",
        "genomic",
        "prostate",
        "test",
        "increase",
        "use",
        "active",
        "surveillance",
        "percent",
        "patient",
        "resulting",
        "greater",
        "adherence",
        "care",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}